about
Experimental comparison of the thrombogenicity of fibrin and PTFE flow surfacesClinical Scenarios for Discordant Anti-XaThrombotic complications of heparin therapy: including six cases of heparin--induced skin necrosisLow molecular weight heparins: an emerging new class of glycosaminoglycan antithrombotics.Heparin-induced thrombocytopenia. A common but controllable condition.Treatment of venous thromboembolic disease. A pragmatic approach to anticoagulation and thrombolysis.Intravascular coagulation. 2. Underlying conditions and therapy.Antithrombin activities in childhood malnutrition.Roles of Coagulation and fibrinolysis in angiotensin II-enhanced microvascular thrombosisHeparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations.Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.In vitro and in vivo correlation of clotting protease activity: effect of heparin.Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.Hypercoagulable states. Their causes and management.Effect of heparin and heparin fractions on platelet aggregationFamilial antithrombin III deficiency and Mycoplasma pneumoniae pneumonia.The impact of inherited thrombophilia on surgery: a factor to consider before transplantation?Pharmacology and clinical applications of human recombinant antithrombin.Scientific considerations in the review and approval of generic enoxaparin in the United States.Low dose heparin prophylaxis.Aspirin and heparin in pregnancy.Screening for heparin binding variants of antithrombin.Acute aortic thrombosis and antithrombin III deficiency in the nephrotic syndrome: a case report.Evidence linking familial thrombosis with a defective antithrombin III gene in two British kindreds.Effect of dextran sulphates on thrombin activityThrombin-Responsive Transcutaneous Patch for Auto-Anticoagulant Regulation.Maternal thrombophilias are associated with specific placental lesions.Side-effects of rinsing fluids on the rat femoral artery. A histological and electron microscopic study.Excessive requirement for heparin during cardiac surgery.Role of the thrombin/protease-activated receptor 1 pathway in intestinal ischemia-reperfusion injury in rats.
P2860
Q24537374-79FC4158-01A3-4443-9A26-1C8BAD7BB021Q26746987-E7EF2B68-34BA-4713-B309-59615B73400DQ28328455-977C9127-3AFC-404B-A5D3-0B891329BBD1Q33370169-4A1BDA50-3964-4364-AA29-C422E6BCDAF9Q33429312-CE6B8900-C68C-4673-AD24-D21475DAFAFCQ33455599-B9DA6609-87AF-4EFA-A33E-BB3A2735802FQ33499472-CF142191-9C4B-4B48-B00C-F48E6806B1A3Q33847574-CFEAB718-F3A2-4AF1-9048-3256C3F70F6EQ33934802-2CEB8163-5108-446C-87BA-8736CF516634Q34394709-11BA3431-F80B-4E36-8691-0EF47C1C37E9Q34576143-F3B6CD9E-8554-4A5C-8913-642359051A29Q35038341-94CFE870-2413-4B00-9767-C2AC1DED9855Q35815979-93B91CF7-7740-4D20-BD46-DC32F269746DQ36783002-CC490D7F-EDB1-48EA-95F9-A0A87D93BBAFQ37019110-1785ECEA-7317-4432-B051-3903F60B1B04Q37138865-B5824618-722F-460A-AB52-224F86B253F5Q37179099-3C4C67CA-FCB8-44F7-9999-4EDC965B0B43Q37763191-69C57984-7F2E-4BBD-824F-B032A2CCD061Q38087496-F57B47C0-A7EE-41DC-B4E6-B0C1667F07F1Q38335205-C02BC8BA-9EEE-41DB-85DB-B0F27B64546DQ38544097-F7B1D487-0A72-4CFA-AC61-18A163D35E37Q39458049-37D3B33A-8CFA-4B7F-A376-BD3D6DB98CD5Q40572036-BC61B37C-0F2D-4BB6-8B29-701CDA800180Q41624441-D340786C-2283-41F0-B5C7-368E497706D1Q41740497-DDC8DE53-C0CD-43BB-9F42-7FBFAE825C97Q44868404-F081CA76-4C2D-4644-BB20-22A460DB11F5Q47569972-3AA4FE86-3EB3-48CD-A046-3EA13027C10FQ51500328-EA3AFD76-1224-4649-8651-ECCDB8E5BCAEQ54535769-BED3826F-60BB-4F6B-903B-F37E7AC261A0Q54577847-4282D079-DB05-4FB1-84E9-626A1DB35E08
P2860
description
1975 nî lūn-bûn
@nan
1975 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Actions and interactions of antithrombin and heparin.
@ast
Actions and interactions of antithrombin and heparin.
@en
type
label
Actions and interactions of antithrombin and heparin.
@ast
Actions and interactions of antithrombin and heparin.
@en
prefLabel
Actions and interactions of antithrombin and heparin.
@ast
Actions and interactions of antithrombin and heparin.
@en
P1476
Actions and interactions of antithrombin and heparin.
@en
P2093
Rosenberg RD
P304
P356
10.1056/NEJM197501162920307
P407
P577
1975-01-01T00:00:00Z